These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 22814721)

  • 41. Innate immune responses in hepatitis B virus (HBV) infection.
    Busca A; Kumar A
    Virol J; 2014 Feb; 11():22. PubMed ID: 24507433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hepatitis B virus (HBV) and the inflammatory/immune response. I. The natural environment of the antigen presentation and immunologic chaos induced by the virus].
    Villarrubia VG; Alvarez-Mon M; Chirigos MA; Herrerías JM
    Rev Esp Enferm Dig; 1997 Dec; 89(12):919-28. PubMed ID: 9494379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice.
    Han Q; Hou Z; Yin C; Zhang C; Zhang J
    Antiviral Res; 2019 Jan; 161():36-45. PubMed ID: 30448255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New insights into how HBV manipulates the innate immune response to establish acute and persistent infection.
    Revill P; Yuan Z
    Antivir Ther; 2013; 18(1):1-15. PubMed ID: 23363957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
    Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
    Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Interactions between HBV and the Innate Immunity of Hepatocytes.
    Megahed FAK; Zhou X; Sun P
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32151000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
    Zhu W; Liu H; Zhang X
    ACS Infect Dis; 2019 May; 5(5):703-712. PubMed ID: 30907080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural killer cell activation contributes to hepatitis B viral control in a mouse model.
    Tong S; Liu G; Li M; Li X; Liu Q; Peng H; Li S; Ren H; Yin W
    Sci Rep; 2017 Mar; 7(1):314. PubMed ID: 28331190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How Far we are towards Eradication of HBV Infection.
    Voiculescu M
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):473-9. PubMed ID: 26697574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of innate immunity in the immunopathology and treatment of HBV infection.
    Maini MK; Gehring AJ
    J Hepatol; 2016 Apr; 64(1 Suppl):S60-S70. PubMed ID: 27084038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The immune response during hepatitis B virus infection.
    Bertoletti A; Gehring AJ
    J Gen Virol; 2006 Jun; 87(Pt 6):1439-1449. PubMed ID: 16690908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative review of HLA associations with hepatitis B and C viral infections across global populations.
    Singh R; Kaul R; Kaul A; Khan K
    World J Gastroenterol; 2007 Mar; 13(12):1770-87. PubMed ID: 17465466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunopathology of hepatitis B virus infection.
    Tsai HT; Tsai TH; Lu TM; Yang CC
    Int Rev Immunol; 2008; 27(6):427-46. PubMed ID: 19065350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection.
    Li J; Han Y; Jin K; Wan Y; Wang S; Liu B; Liu Y; Lu S; Huang Z
    Virol J; 2011 May; 8():199. PubMed ID: 21535873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review article: novel therapies for hepatitis B virus cure - advances and perspectives.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2016 Aug; 44(3):213-22. PubMed ID: 27302653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
    Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection.
    Martinet J; Dufeu-Duchesne T; Bruder Costa J; Larrat S; Marlu A; Leroy V; Plumas J; Aspord C
    Gastroenterology; 2012 Dec; 143(6):1586-1596.e8. PubMed ID: 22960656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.
    Han Q; Lan P; Zhang J; Zhang C; Tian Z
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():132-7. PubMed ID: 23855309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.